期刊文献+

风湿病患者中糖皮质激素性骨质疏松的诊治值得关注 被引量:2

原文传递
导出
摘要 风湿性疾病可造成多系统多脏器功能损害,近年来,随着对原发病诊治水平的提高,患者的预后得到明显改善。但是,继发骨质疏松症,尤其是应用糖皮质激素引起的骨质疏松(GIOP)越来越成为影响患者生活质量的重要问题。如何正确认识GIOP,如何作到早期诊断及规范治疗,在临床上还未引起足够重视。本文旨在提高对GIOP的警惕,及早进行有效的防治,尽可能避免出现GIOP以及骨折等严重后果。
作者 张学武
出处 《中华风湿病学杂志》 CAS CSCD 2008年第10期657-659,共3页 Chinese Journal of Rheumatology
  • 相关文献

参考文献14

  • 1Mckenzie R, Reynolds JC, O'Fallon A, et al. Decreased bone mineral density during low dose glucocnrticoid administration in a randomized, placebo controlled trial. J Rheumatol. 2000, 27: 2222-2226.
  • 2Van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osleoporos Int, 2002, 13: 777-787.
  • 3Angeli A Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study'. Bone, 2006, 39: 253-259.
  • 4Kaji H, Yamauchi M, Chihara K, et al. The threshold of bone mineral density for vertebral fracture in female patients with glucocortieoid-induced osteoporosis. Endocr J, 2006, 53: 27-34.
  • 5Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, et al. Disease activity and disability but probably not glucoeorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol, 2008, 37: 248- 254.
  • 6Lee C, Almagor O, Dunlop DD. et al. Disease damage and low bone mineral density:an analysis of women with systemic lupus erythematosus ever and never receiving cort-icosteroids. Rheumatology( Oxford ), 2006, 45: 53-60.
  • 7Recommendations for the prevention and glueocortieoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis. Arthritis Rheum, 2001, 44: 1496-1503.
  • 8Hoes JN, Jacobs JWG, Boers M, et al. EULAR evidence-based recommendations on the management of systemic glueocorticoid therapy in rheumatic diseases. Ann Rheum Dis, 2007, 66: 1560-1567.
  • 9Buckley LM, Leib ES, Cartularu KS, et al. Calcium and vitamin D supplementation prevents bone loss in the spine secondary to low dose eorticosteroids in patients with rheumatoid arthritis. Ann Intern Med, 1996, 125: 961-968.
  • 10De nijs RN, Jacobs JW, Algra A, et al. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos lnt, 2004, 15: 589-602.

同被引文献21

  • 1陈顺科.糖皮质激素诱发精神异常2例[J].中国药业,2006,15(20):26-26. 被引量:7
  • 2廖二元,莫朝晖.内分泌学[M].2版.北京:人民卫生出版社,2010:660.
  • 3Feigl GC, Pistracher K, Berghold A, et al. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas : the role of the hypothalamus[J]. J Neurosurg, 2010, 113 Suppl: 153-159.
  • 4Harsch IA, Schuller A, Hahn EG, et al. Cortisone replacement therapy in endocrine disorders-quality of self-care [ J]. J Eval Clin Pract, 2010, 16(3) :492-498.
  • 5Kristjansdottir HL, Bodvarsdottir SP, Sigurjonsdottir HA. Sheehan' s syndrome in modem times : a nationwide retrospective study in Iceland[J]. Eur J Endoerinol, 2011, 164(3) :349-354.
  • 6Neary N, Nieman L. Adrenal insufficiency : etiology, diagnosis and treatment [ J ]. Curr Opin Endoerinol Diabetes Obes, 2010, 17 (3) :217-223.
  • 7Laway BA, Bhat JR, Mir SA, et al. Shechan's syndrome with pan- cytopenia-eomplete recovery after hormone replacement ( case series with review)[J]. Ann Hematol, 2010, 89(3) :305-308.
  • 8徐西嘉,唐劲松,郭文斌.糖皮质激素所致精神障碍2例[J].临床精神医学杂志,2007,17(5):334-334. 被引量:17
  • 9张晓.重视风湿病治疗中糖皮质激素诱发的骨质疏松[J].中华内科杂志,2008,47(5):357-358. 被引量:1
  • 10卢春燕,张林,徐梁,陈德才,王覃,刘娜,魏松全,贾丹,袁丽.一家大型医院住院患者骨质疏松症诊治现状的初步调查[J].中华骨质疏松和骨矿盐疾病杂志,2010,3(1):43-48. 被引量:15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部